Trial Profile
A 17 week, investigator-initiated, single-center, double-blind, randomized, placebo-controlled, cross-over trial of pregabalin in essential tremor
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 16 Mar 2021
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Essential tremor
- Focus Therapeutic Use
- 15 Oct 2009 Results published in the Journal of the Neurological Sciences.
- 07 Jun 2009 Results presented at the 13th International Congress of Parkinson's Disease and Movement Disorders.
- 07 Jun 2009 Primary endpoint 'Tremor Clinical Rating Scale' has not been met according to results presented at the 13th International Congress of Parkinson's Disease and Movement Disorders.